Certara adds to its COVID-19 toolkit with virtual trials moduleDrugmakers have been working with data specialist Certara on a new tool that they hope could speed up Share XCertara adds to its COVID-19 toolkit with virtual trials modulehttps://pharmaphorum.com/news/certara-adds-to-its-covid-19-toolkit-with-virtual-trials-module/
Roche’s ulcerative colitis drug etrolizumab looks shaky after data roll-outRoche’s late-stage trial programme for ulcerative colitis candidate etrolizumab has generated some positive and negative results, but leans Share XRoche’s ulcerative colitis drug etrolizumab looks shaky after data roll-outhttps://pharmaphorum.com/news/roches-ulcerative-colitis-drug-etrolizumab-looks-shaky-after-data-roll-out/
Gilead files COVID-19 drug remdesivir with FDAGilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the Share XGilead files COVID-19 drug remdesivir with FDAhttps://pharmaphorum.com/news/gilead-files-covid-19-drug-remdesivir-with-fda/
Coronavirus pharma news roundup – 07/08/20Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Share XCoronavirus pharma news roundup – 07/08/20https://pharmaphorum.com/r-d/views-analysis-r-d/coronavirus-pharma-news-roundup-07-08-20/
Post-viral syndrome: Learning to live with COVID-19 on the NHSRecent months have exacerbated many of the issues that were facing the NHS before anyone had ever heard Share XPost-viral syndrome: Learning to live with COVID-19 on the NHShttps://pharmaphorum.com/views-and-analysis/post-viral-syndrome-covid-19-nhs/
Tackling multimorbidity through collaborationAs populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the Share XTackling multimorbidity through collaborationhttps://pharmaphorum.com/views-analysis-patients/tackling-multimorbidity-through-collaboration/
GSK’s John Fleming on rethinking oncology from the ground upWhat if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s Share XGSK’s John Fleming on rethinking oncology from the ground uphttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/gsks-john-fleming-on-rethinking-oncology-from-the-ground-up/
Commercialising innovative new medicinesAs pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination Share XCommercialising innovative new medicineshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/commercialising-innovative-new-medicines/
How to increase haematologists’ and oncologists’ confidence with new treatmentsA new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments Share XHow to increase haematologists’ and oncologists’ confidence with new treatmentshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/how-to-increase-haematologists-and-oncologists-confidence-with-new-treatments/
Clinical decision-making insights for haem/oncs Share XClinical decision-making insights for haem/oncshttps://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/
How to win with a multichannel approach in pharma Share XHow to win with a multichannel approach in pharmahttps://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/
Accelerating pharma’s digital IQ as customer engagement evolves Share XAccelerating pharma’s digital IQ as customer engagement evolveshttps://pharmaphorum.com/digital/veeva-customer-engagement-webinar/
Customer experience in healthcare – a strategic priority for pharmaCustomer experience (CX) is widely, and rightly, acknowledged to be one of the pharmaceutical industry’s top strategic priorities. Share XCustomer experience in healthcare – a strategic priority for pharmahttps://pharmaphorum.com/whitepapers/customer-experience-strategy-healthcare-pharma/
Preparing for the next decade of innovation in immuno-oncologyImmuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic Share XPreparing for the next decade of innovation in immuno-oncologyhttps://pharmaphorum.com/oncology/immuno-oncology-clinicial-trial-market-access/
Pharma’s roadmap for successful online engagement with HCPsHealthcare professionals (HCPs) rate websites as their number one source for clinical practice information and mobile technology has Share XPharma’s roadmap for successful online engagement with HCPshttps://pharmaphorum.com/sales-marketing/pharma-roadmap-online-hcp-engagement/
Novartis, company culture and COVID-19: the pharmaphorum podcast Share XNovartis, company culture and COVID-19: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-company-culture-covid-19/
Investing in innovation – new digital approaches for a new decade Share XInvesting in innovation – new digital approaches for a new decadehttps://pharmaphorum.com/views-analysis-digital/investing-in-innovation-new-digital-approaches-for-a-new-decade/
China’s COVID-19 experience – the Health Heroes podcast Share XChina’s COVID-19 experience – the Health Heroes podcasthttps://pharmaphorum.com/podcast/china-experience-covid-19-pandemic/
Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington medicines powerhouse Share XMedicines Discovery Catapult awarded funding to establish Cheshire & Warrington medicines powerhousehttps://pharmaphorum.com/partner-content/medicines-discovery-catapult-awarded-funding-to-establish-cheshire-warrington-medicines-powerhouse/
Survey finds quality control is a major challenge in clinical labeling Share XSurvey finds quality control is a major challenge in clinical labelinghttps://pharmaphorum.com/partner-content/press-releases/survey-finds-quality-control-is-a-major-challenge-in-clinical-labeling/
Important factors to consider when working with CRFs Share XImportant factors to consider when working with CRFshttps://pharmaphorum.com/partner-content/press-releases/important-factors-to-consider-when-working-with-crfs/
J+D Forecasting Change the Forecasting Approach of a Global Bio Tech Share XJ+D Forecasting Change the Forecasting Approach of a Global Bio Techhttps://pharmaphorum.com/partner-content/jd-forecasting-change-the-forecasting-approach-of-a-global-bio-tech/
Prescient Announces Recent Appointments to the Senior Advisory Team Share XPrescient Announces Recent Appointments to the Senior Advisory Teamhttps://pharmaphorum.com/partner-content/prescient-announces-recent-appointments-to-the-senior-advisory-team/
Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team Share XPrescient Intelligence & Insight Announces Recent Appointments to the Senior Teamhttps://pharmaphorum.com/partner-content/prescient-intelligence-insight-announces-recent-appointments-to-the-senior-team-2/
